Mirae Asset Global Investments’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $317K | Buy |
7,335
+971
| +15% | +$41.9K | ﹤0.01% | 995 |
|
|
2025
Q1 | $223K | Buy |
6,364
+66
| +1% | +$2.32K | ﹤0.01% | 1030 |
|
|
2024
Q4 | $176K | Sell |
6,298
-503
| -7% | -$14.1K | ﹤0.01% | 1060 |
|
|
2024
Q3 | $170K | Buy |
6,801
+1,214
| +22% | +$30.3K | ﹤0.01% | 1115 |
|
|
2024
Q2 | $141K | Sell |
5,587
-56,157
| -91% | -$1.42M | ﹤0.01% | 1096 |
|
|
2024
Q1 | $1.16M | Sell |
61,744
-4,029
| -6% | -$75.9K | ﹤0.01% | 1452 |
|
|
2023
Q4 | $2.66M | Buy |
65,773
+904
| +1% | +$36.5K | 0.01% | 1132 |
|
|
2023
Q3 | $1.71M | Sell |
64,869
-3,481
| -5% | -$91.8K | ﹤0.01% | 1248 |
|
|
2023
Q2 | $1.17M | Buy |
68,350
+7,498
| +12% | +$129K | ﹤0.01% | 1473 |
|
|
2023
Q1 | $1.01M | Buy |
60,852
+13,426
| +28% | +$223K | ﹤0.01% | 1541 |
|
|
2022
Q4 | $361K | Buy |
47,426
+83
| +0.2% | +$632 | ﹤0.01% | 2055 |
|
|
2022
Q3 | $471K | Buy |
47,343
+13,363
| +39% | +$133K | ﹤0.01% | 1896 |
|
|
2022
Q2 | $308K | Buy |
+33,980
| New | +$308K | ﹤0.01% | 1975 |
|
|
2021
Q4 | – | Sell |
-6,085
| Closed | -$285K | – | 1585 |
|
|
2021
Q3 | $285K | Buy |
+6,085
| New | +$285K | ﹤0.01% | 1621 |
|